Cited by 24Viral Infections and Immunology ResearchKawasaki Disease and Coronary ComplicationsStreptococcal Infections and Treatments

Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database

Open access
Ozierański, Krzysztof, Tymińska, Agata, Kruk, Marcin, Koń, Beata, Skwarek, Aleksandra, Opolski, Grzegorz, Grabowski, Marcin·2021·Journal of Clinical Medicine

Abstract

The epidemiology of myocarditis is unknown and based mainly on small single-centre studies. The study aimed to evaluate the current incidence, clinical characteristics, management and outcomes of patients hospitalized due to myocarditis in a general population. The study was registered in ClinicalTrials.gov (NCT04827706). The nationwide MYO-PL (the occurrence, trends, management and outcomes of patients with myocarditis in Poland) database (years 2009–2020) was created to identify hospitalization records with a primary diagnosis of myocarditis according to the International Classification of Diseases and Related Health Problems, 10th Revision (ICD 10), derived from the database of the national healthcare insurer. We identified 19,978 patients who were hospitalized with suspected myocarditis for the first time, of whom 74% were male. The standardized incidence rate of myocarditis ranged from 1.15 to 14 per 100,000 people depending on the age group and was the highest in patients aged 16–20 years. The overall incidence increased with time. The performance of the recommended diagnostic tests (in particular, endomyocardial biopsy) was low. Relative five-year survival ranged from 0.99 to 0.56—worse in younger females and older males. During a five-year follow-up, 6% of patients (3.7% and 6.9% in females and males, respectively) were re-hospitalized for myocarditis. Surprisingly, females more frequently required hospitalization due to heart failure/cardiomyopathy (10.5%) and atrial fibrillation (5%) than compared to males (7.3% and 2.2%, respectively) in the five-year follow up. In the last ten years, the incidence of suspected myocarditis increased, particularly in males. Survival rates for patients with myocarditis were worse than in the general population. Management of myocarditis requires significant improvement.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10204672

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Women are more likely to develop myocarditis after menopause.

    “while women are more likely to develop myocarditis after menopause, which is reviewed in previous studies. 64,113-117”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [116]

    Study Population and Clinical Characteristics (section 3.1; page unavailable) reports that the proportion of female patients relative to male patients increased with age and was highest in the oldest groups. It does not assess menopausal status or establish that women become more likely to develop myocarditis after menopause. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Pre-COVID myocarditis occurs more often in young men under 50 years, with a sex ratio of 2 to 4:1 men to women.

    “Myocarditis pre-COVID is known to occur more often in young men under the age of 50 years, with a sex ratio of 2 to 4:1 men to women”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [116]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ozierański, K., Tymińska, A., Kruk, M., Koń, B., Skwarek, A., Opolski, G., & Grabowski, M.
Affiliations
  • Medical University of Warsaw (PL)
  • National Health Fund, 02-528 Warsaw, Poland
Corresponding author
Tymińska, Agata
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2021-10-12
Volume
10
Issue
20
Pages
4672
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3206129070
Cited by
23
References
27
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 1
FWCI
2.85
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Surgery › Kawasaki Disease and Coronary Complications
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
Keywords
myocarditis, incidence, hospitalization, survival, hospital readmission, endomyocardial biopsy, diagnostic testing, sex differences, heart failure, cardiomyopathy, atrial fibrillation, Poland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review